126
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial

, , , , &
Pages 1301-1307 | Published online: 19 Sep 2016

References

  • RobertsROJacobsenSJJacobsonDJReillyWTTalleyNJLieberMMNatural history of prostatism: high American urological association symptom scores among community-dwelling men and women with urinary incontinenceUrology19985122132199495700
  • AthanasopoulosAChappleCFowlerCThe role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an updateEur Urol20116019410521497434
  • WassonJHRedaDJBruskewitzRCElinsonJKellerAMHendersonWGA comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on transurethral resection of the prostateN Engl J Med1995332275797527493
  • HoHSYipSKLimKBFookSFooKTChengCWA prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) systemEur Urol200752251752217416453
  • RassweilerJTeberDKuntzRHofmannRComplications of transurethral resection of the prostate (TURP) – incidence, management, and preventionEur Urol200650596998016469429
  • MarszalekMPonholzerAPusmanMTransurethral resection of the prostateEur Urol2009Suppl 8504512
  • MinDSChoHJKangJYYooTKChoJMEffect of transurethral resection of the prostate based on the degree of obstruction seen in urodynamic studyKorean J Urol2013541284084524363865
  • KangYJKimKHSeoYLeeKSEffect of transurethral resection of the prostate on storage symptoms in patients with benign prostatic hyperplasia of less than 30 mlWorld J Mens Health2013311646923658868
  • ChappleCRSmithDThe pathophysiological changes in the bladder obstructed by benign prostatic hyperplasiaBr J Urol19947321171237510572
  • YamaguchiOKakizakiHHommaYSolifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms – ASSIST, randomized controlled studyUrology201178112613321601248
  • OelkeMBachmannADescazeaudAEAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstructionEur Urol201364111814023541338
  • LiMCWangZYYangJEfficacy and safety of solifenacin plus tamsulosin oral controlled absorption system in men with lower urinary tract symptoms: a meta-analysisAsian J Androl201517112413425337836
  • HaoNTianYLiuWAntimuscarinics and alpha-blockers or alpha-blockers monotherapy on lower urinary tract symptoms – a meta-analysisUrology20148355656224361007
  • JohnsonTM2ndMarklandADGoodePSEfficacy of adding behavioural treatment or antimuscarinic drug therapy to alpha-blocker therapy in men with nocturiaBJU Int201311210010823448285
  • KaplanSARoehrbornCGAbramsPChappleCRBavendamTGuanZAntimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic reviewInt J Clin Pract201165448750721210910
  • XinZHuangYLuJZhangQChenCAddition of antimuscarinics to alpha-blockers for treatment of lower urinary tract symptoms in men: a meta-analysisUrology201382227027723896090
  • HanHHKoWJYooTKFactors associated with continuing medical therapy after transurethral resection of prostateUrology201484367568025059592